Liver Bioservices

🎄✨ Merry Christmas and a Happy New Year! ✨🎄 Warm wishes from all of us at Barcelona Liver Bioservices. Thank you for being part of our journey— here’s to a healthy, successful, and innovative year ahead! 🌟

🎉 Celebrating 8 years of innovation at Barcelona Liver Bioservices! Together with our partners, we’re accelerating drug development to fight liver diseases. 💚🧬 Excited to keep expanding our innovative portfolio and launching new projects at the boundaries of liver research!

The Best Communication Award at the 3rd International Workshop on Liver and Gut Fibrosis goes to @Maria_andresdr from @LiverBio for her presentation on a microfluidic human liver slice model for drug screening (see description) Congrats to María & thanks to sponsor @Biomol_MDPI

📢 New study from BLB❗️ Sex-specific differences in liver disease models show males with more fibrosis & inflammation, females with distinct endothelial & fibrotic traits. Part of our R&D, committed to 3Rs & translational research. Free read 🔗 bsd.biomedcentral.com/articles/10.11…

Season Greetings from Barcelona Liver Bioservices! 🎄💫 We’re grateful for all the collaborations in advancing #liver disease #research. Here’s to a successful 2025 filled with new diacoveries and impactful partnerships! 🥂 #HappyHolidays

Warmest holiday greetings to the entire scientific community from BLB! May this festive season bring you joy, inspiration, and breakthrough discoveries. Wishing you a Merry Christmas and a prosperous New Year filled with scientific achievements!🔬#MerryChristmas #HappyNewYear2024

Our Team Matters Beyond Biomedical Research ➡️ liver.barcelona/barcelona-live…

#LiverTwitter #hepatology #liverdiseases #sinusoid #aCDL #innovation #preclinicalmodels #clinicalresearch #3Dmodels #livercells #biomedicine #biotechnology #pharma #development #NASH #Cirrhosis #NAFLD #partnership

Have you ever thought about the importance of hepatic microcirculation in liver diseases? Understanding the mechanisms involved in hepatic microvascular is crucial for diagnosing and managing liver disorders 📢Check out our latest publication on Linkedin linkedin.com/feed/update/ur…

Happy holidays from the entire BLB’s team! This holiday season we celebrate 5 years developing preclinical research in Hepatology 💫

Latest BLB research published in the Journal of Hepatology: liver.barcelona/latest-blb-res…

Fresh from the oven! Very happy to share with you our latest collaborative work, just published in @JHepatology: 📖 Pan-PPAR agonist lanifibranor improves portal hypertension and hepatic fibrosis in experimental #cirrhosis Open access ➡️ doi.org/10.1016/j.jhep… #livertwitter

#livertwitter 📌 Lanifibranor shown to be effective in NASH in a phase2b RCT of 24 week Rx ✳️ Meets all primary end-points for NASH of both FDA and EMA & reduces fibrosis ✳️ Data in a press release by Inventiva ✳️ The RCT confirms our study in cirrhotic rats at last AASLD

A major hurdle in drug development is correctly identifying candidates with low liver toxicity.💊 The "Liver on a Chip" platform by @idibaps spin-off and #CaixaImpulse project ExoLiver mimics the liver environment, allowing proper toxicology testing. 👇 caixaimpulse.com/en_US/projects…

Season’s Greetings from the Barcelona Liver Bioservices Team!

Today at the #LiverMtg19 Zoe Boyer-Diaz, senior associate scientist, presents the work “hepatic fatty acid profile in chronic #liver #disease: mechanism of injury and novel therapeutic target”. Come by to the posters area and learn about this and other projects of BLB!

Great Early Morning Workshop together with Prof. Natalie Török @StanfordUniver the Liver Meeting 2019 #Boston @AASLDtweets and excellent presentations from Dr. Pedro Rodrigues @PMRodrigues19 @Biodonostia and Peio Aristu @LiverBio @unicomplutense

Dr Gracia-Sancho @jsgracia, presents the effects and underlying mechanisms of 2-week lanifibranor on portal hypertension, hepatic microcirculatory dysfunction and liver fibrosis in pre-clinical advanced cirrhosis. #NASH #LiverMtg19

Glad to announce our participation in the upcoming #LiverMtg19 in #Boston!! Our team looks forward to sharing our science and meeting current & new partners! Click to know more 👉🏼 liver.barcelona/barcelona-live…

Happy to announce the publication of the manuscript “A nutraceutical rich in DHA improves portal hypertension in #cirrhosis” in the journal @Nutrients_MDPI. Fruit of our collaboration with BrudyLab. Read here the press release: liver.barcelona/a-nutraceutica… #liver